Fábio Aguiar-Alves
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 16
-
- Streptococcal Infections and Treatments 5
- Research on Leishmaniasis Studies 3
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing 8
- Parasitology top 10%
-
- Bacterial biofilms and quorum sensing 14
-
- Antimicrobial Peptides and Activities 5
-
- Education Pedagogy and Practices 3
-
- Pneumonia and Respiratory Infections 3
- Co-authors
- Meredith L. TuretzEdgar M. CarvalhoRoque Pacheco de AlmeidaAchiléa Lisbôa BittencourtPaulo Roberto Lima MachadoAlbert I. KoNiloufar MobasheryWarren D. Johnson
- Cited by
- Infectious DiseasesPublic Health, Environmental and Occupational HealthClinical Biochemistry
- Journals
- Proceedings of the National Academy of Sciences (1 paper)SHILAP Revista de lepidopterología (4 papers)Journal of Clinical Microbiology (1 paper)
- Partner nations
- BrazilUnited StatesFrance
In The Last Decade
Fábio Aguiar-Alves
51 papers receiving 621 citations
Peers
Comparison fields: 5 of 101
- Infectious Diseases 211
- Public Health, Environmental and Occupational Health 298
- Clinical Biochemistry 59
- Parasitology 47
- Applied Microbiology and Biotechnology 13
Countries citing papers authored by Fábio Aguiar-Alves
This map shows the geographic impact of Fábio Aguiar-Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fábio Aguiar-Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fábio Aguiar-Alves more than expected).
Fields of papers citing papers by Fábio Aguiar-Alves
This network shows the impact of papers produced by Fábio Aguiar-Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fábio Aguiar-Alves. The network helps show where Fábio Aguiar-Alves may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fábio Aguiar-Alves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2017 | 18 | |
| 14 | 2015 | 6 | |
| 15 | 2014 | 7 | |
| 16 | 2014 | 33 | |
| 17 | 2010 | 7 | |
| 18 | 2010 | 7 | |
| 19 | 2009 | 3 | |
| 20 | 2002 | 143 |
About Fábio Aguiar-Alves
Fábio Aguiar-Alves is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Clinical Biochemistry, having authored 54 papers that have together received 634 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (16 papers), Bacterial biofilms and quorum sensing (14 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antimicrobial Peptides and Activities (5 papers), Streptococcal Infections and Treatments (5 papers), Education Pedagogy and Practices (3 papers), Research on Leishmaniasis Studies (3 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Infectious Diseases (211 citations), Public Health, Environmental and Occupational Health (298 citations) and Clinical Biochemistry (59 citations). Fábio Aguiar-Alves has collaborated with scholars based in Brazil, United States and France. Frequent co-authors include Meredith L. Turetz, Edgar M. Carvalho, Roque Pacheco de Almeida, Achiléa Lisbôa Bittencourt, Paulo Roberto Lima Machado, Albert I. Ko, Niloufar Mobashery, Warren D. Johnson, Leonor L. Leon and Léa Cysne‐Finkelstein. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.